Skip to main content

Arax Advisory Partners

Position in MREO — Mereo BioPharma Group plc

CIK 1586767 DENVER, CO

Position in MREO

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$1,850
+$530 QoQ
Shares Held
5,819
+45.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 58 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 31% Shared 0% None 69%

Common Shares in MREO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Arax Advisory Partners holds $59,653,938 across 287 Biotechnology names. MREO ranks #233 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MREO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,850 5,819
2026-03-31 $1,320 4,000
2025-12-31 $1,668 4,000
2025-09-30 $8,240 4,000
2025-06-30 $10,840 4,000
2025-03-31 $9,000 4,000
2024-12-31 $14,000 4,000
2024-09-30 $16,440 4,000
2024-06-30 $14,400 4,000
2024-03-31 $13,200 4,000
2023-12-31 $9,240 4,000
2023-09-30 $5,160 4,000
2023-06-30 $5,280 4,000
2023-03-31 $2,828 4,000
2022-12-31 $3,000 4,000
2022-09-30 $3,444 4,000
2022-06-30 $4,480 4,000
2022-03-31 $4,480 4,000
2021-12-31 $6,400 4,000
2021-09-30 $9,680 4,000